报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | -0.06% | 92% | 93.41% | 32/51 | 0.99% | 药明康德 | 9.08% | 行业排名> |
2024-12-31 | -0.91% | 59.56% | -3.41% | 30/51 | -1.19% | 澳洋健康 | 12.87% | 行业排名> |
2024-09-30 | -0.88% | -6.02% | 26.67% | 38/51 | 3.32% | 澳洋健康 | 28.53% | 行业排名> |
2024-06-30 | -1.2% | -79.1% | -60% | 39/51 | 2.09% | 澳洋健康 | 34.16% | 行业排名> |
2024-03-31 | -0.75% | 8.54% | 66.67% | 38/51 | 1.19% | 澳洋健康 | 30.56% | 行业排名> |
2023-12-31 | -2.25% | -34.73% | -171.08% | 40/51 | 3.7% | 澳洋健康 | 28.14% | 行业排名> |
2023-09-30 | -0.83% | -106.96% | -23.88% | 43/51 | 6.82% | 澳洋健康 | 39.54% | 行业排名> |
2023-06-30 | -0.67% | -67.5% | 18.29% | 42/51 | 1.93% | 澳洋健康 | 61.84% | 行业排名> |
2023-03-31 | -0.82% | -205.13% | 50.9% | 40/51 | 2.58% | 澳洋健康 | 48.34% | 行业排名> |
2022-12-31 | -1.67% | -109.08% | -317.5% | 37/51 | -0.62% | 澳洋健康 | 58.19% | 行业排名> |
2022-06-30 | -0.4% | -104.42% | -151.28% | 39/51 | 5.56% | *ST宜康 | 75.53% | 行业排名> |
2022-03-31 | 0.78% | 2% | -95.76% | 31/51 | 3.14% | 博腾股份 | 39.77% | 行业排名> |
2021-12-31 | 18.39% | 20.43% | 54.28% | 14/51 | -6.68% | 睿智医药 | 41.16% | 行业排名> |
2021-09-30 | 11.92% | 2% | 31.57% | 15/51 | 2.3% | 澳洋健康 | 51.68% | 行业排名> |
2021-06-30 | 9.06% | 171.26% | -40.67% | 15/51 | 2.28% | 澳洋健康 | 40.93% | 行业排名> |
2020-12-31 | 15.27% | 52.4% | 357.19% | 22/51 | 10.95% | 金域医学 | 43.58% | 行业排名> |
2020-06-30 | 3.34% | -62.76% | -66.67% | 24/51 | 2.48% | 金域医学 | 35.41% | 行业排名> |
2019-12-31 | 10.02% | 218.1% | 218.1% | 27/51 | 65.31% | 阳光诺和 | 26.2% | 行业排名> |
2018-12-31 | 3.15% | 51.44% | -64.88% | 34/51 | -0.6% | 金域医学 | 13.23% | 行业排名> |
2018-06-30 | 8.97% | 2% | 331.25% | 6/51 | 1.51% | 万邦医药 | 52.05% | 行业排名> |
2017-12-31 | 2.08% | 2% | 2% | 35/51 | 1.73% | 华大基因 | 48.52% | 行业排名> |